Tackling disordered proteins (IMAGE)
Caption
This illustration shows the dynamic interactions of anti-cancer drug EGCG with the transactivation domain (TAD) of tumor suppressor protein p53.
Credit
UMass Amherst/Chen Lab
Usage Restrictions
None
License
Original content